SeraCare Life Sciences (SRLS) Higher On Multiple HIV Contracts from the CDC and NIH
Tweet Send to a Friend
Shares of SeraCare Life Sciences (NASDAQ: SRLS) are 27% higher in pre-open action after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
